Leran more
Leran more
AI VIVO is positioned to fully capture the value of the Organome Technology by leveraging 4 types of strategic collaborations with selected partners:
Organome Platform Discovery
Partnership
Cell engineering
& Conversion
Partnership
In vivo reprogramming
Therapy Partnership
Organ Level Asset Generation
Partnership Leran more
Leran more
Jointly develop mechanisms for organ level disease modulation
Jointly develop candidates for organ level disease modulation
Jointly hit-to-lead, lead optimisation, and IND development
Contact us to learn more
Discover unexpected organ level disease mechanisms and identify corresponding novel therapeutic modalities.
Organ level drug repositioning
Leveraging the Organome platform to build value adding partnerships with Pharma and biotech companies. Organome Platform Discovery
Partnership
